Cancer Illumination™

Discover the latest in imaging advancements with Cancer Illumination™. Using the Synergy Vision™ imaging system and pafolacianine (CYTALUX® imaging agent), an FDA-approved prescription medication, surgeons can now visualize cancerous cells that may have otherwise gone undetected.

CYTALUX is a registered trademark of On Target Laboratories, Inc.

Resource Type:
Publication Date:
Duration:
Reference Number:
Version: